Related Experiment Video
Updated: Oct 11, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer
T Hattori1, N Ookawa, R Fujita
1Department of Gastroenterology, Fujigaoka Hospital, Showa University, Yokohama, Japan. thattori@tka.att.ne.jp
Abstract:
The rate of cell loss owing to apoptosis is mediated by competitive dimerization with selective pairs of cell death antagonists (Bcl-2, Bcl-X(L)) and agonists (Bax, Bad). The aim of this study was to investigate which Bcl-2 family dimers had a critical factor in colorectal cancer. We analyzed the expression of Bcl-2, Bcl-X(L), Bax, and Bad in normal-appearing mucosa and colorectal tumor tissues by Western blotting after immunoprecipitation. Compared with the ratio of Bax-Bcl-2/total Bax in normal mucosa, the ratio was significantly reduced in tumors (p = 0.02). In this series, the low ratio of Bad-Bcl-2/total Bcl-2 was associated with advanced tumor stages (p = 0.02). A reduced heterodimerization of Bax with Bcl-2 may contribute to the development of colorectal cancer. The heterodimerization of Bad with Bcl-2 may be repressed in advanced tumor tissues, and may contribute to tumor growth in colorectal cancer.
Insights
Altered dimerization of Bcl-2 family proteins, specifically reduced Bax-Bcl-2 and Bad-Bcl-2 interactions, is linked to colorectal cancer development and progression. These changes in apoptosis regulation are critical factors in tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Apoptosis, or programmed cell death, is regulated by Bcl-2 family proteins.
- These proteins form dimers, acting as either antagonists (e.g., Bcl-2) or agonists (e.g., Bax, Bad) of cell death.
- Dysregulation of these interactions is implicated in various cancers.
Purpose of the Study:
- To investigate the role of specific Bcl-2 family protein dimers in colorectal cancer.
- To determine if altered dimerization patterns correlate with tumor development and stage.
Main Methods:
- Western blotting after immunoprecipitation was used to analyze protein expression.
- Expression levels of Bcl-2, Bcl-X(L), Bax, and Bad were quantified.
- Ratios of specific heterodimers (Bax-Bcl-2, Bad-Bcl-2) were compared between normal mucosa and tumor tissues.
Main Results:
- The ratio of Bax-Bcl-2/total Bax was significantly reduced in colorectal tumors compared to normal mucosa (p=0.02).
- A low ratio of Bad-Bcl-2/total Bcl-2 was associated with advanced tumor stages (p=0.02).
Conclusions:
- Reduced heterodimerization of Bax with Bcl-2 may promote colorectal cancer development.
- Repressed heterodimerization of Bad with Bcl-2 in advanced tumors could contribute to tumor growth.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inflammatory Bowel Disease III: Crohn's Disease